サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1552516

ホルモン避妊薬市場、規模、シェア、動向、産業分析レポート：製品別、ホルモン別、流通チャネル別、地域別- 市場予測、2024年～2032年

Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product, By Hormone, By Distribution Channel, and By Region - Market Forecast, 2024 - 2032

出版日
ページ情報
英文 126 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ホルモン避妊薬市場、規模、シェア、動向、産業分析レポート：製品別、ホルモン別、流通チャネル別、地域別- 市場予測、2024年～2032年
出版日: 2024年08月01日
発行: Polaris Market Research
ページ情報: 英文 126 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のホルモン避妊薬市場規模は2032年までに246億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界のホルモン避妊薬市場は、家族計画やリプロダクティブヘルスに対する意識の高まり、信頼できる避妊法としてのホルモン避妊薬の採用率の上昇、避妊技術の進歩などを背景に、力強い成長を遂げています。主な促進要因としては、女性の健康とエンパワーメントの重視の高まり、避妊薬へのアクセスを促進する政府の支援的な取り組みや政策、予防措置を促す性感染症（STI）の有病率の上昇などが挙げられます。市場の動向は、長時間作用型可逆的避妊薬（LARC）のような革新的なホルモン避妊薬へのシフトや、経口避妊薬やホルモンパッチのような個別化された便利な選択肢への需要の高まりを示しています。

新興市場におけるホルモン避妊薬市場は、ヘルスケアインフラの進歩や経済状況の改善に牽引され、大きな成長を遂げています。また、ヘルスケアシステムへの投資により、様々な避妊オプションへのアクセスが拡大し、ホルモン性避妊薬がより広く利用できるようになっています。経済的安定が高まったことで、より多くの個人が余裕を持ち、家族計画サービスを優先できるようになった。さらに、リプロダクティブヘルスに対する認識と教育の高まりも、需要の増加に寄与しています。政府や組織も、公衆衛生への取り組みや補助金を通じてアクセス改善に注力しており、利用可能性をさらに高めています。このような市場の拡大は、新興国の女性にとってより良いリプロダクティブヘルス（性と生殖に関する健康）の選択肢とエンパワーメントへの前向きなシフトを反映しています。

ホルモン避妊薬市場のレポートハイライト

経口避妊薬は、広く使用され、有効性が確立され、消費者に長年親しまれているため、依然として主要な分野です。

プロゲスチン単独ピル、インプラント、注射などの方法を含むプロゲスチン単独避妊薬は、エストロゲンを使用できない女性や単独ホルモンによるアプローチを好む女性に適しているため、人気が高まっています。

現在、小売薬局が市場を独占しているのは、消費者にとって広く利用しやすく便利だからです。

最も成長しているセグメントは病院薬局です。この成長には、ヘルスケアへのアクセスの増加と、臨床現場における包括的なリプロダクティブヘルスサービスへの注目の高まりが寄与しています。

北米が市場を独占し、アジア太平洋が最も高い成長率を示すと予想されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のホルモン避妊薬市場の洞察

  • 市場スナップショット
  • ホルモン避妊薬市場力学
    • 促進要因と機会
      • 長期作用型可逆的避妊薬（LARC）の需要増加が市場の成長を牽引
      • パーソナライズされた便利な避妊法への移行が市場を牽引
    • 抑制要因と課題
      • 健康上の懸念と副作用がホルモン避妊薬市場の成長を妨げている
  • PESTEL分析
  • ホルモン避妊薬市場の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のホルモン避妊薬市場： 製品別

  • 主な調査結果
  • イントロダクション
  • 錠剤
  • 皮膚パッチ
  • ホルモンインプラント
  • 膣リング
  • 皮膚パッチ
  • その他

第6章 世界のホルモン避妊薬市場：ホルモン別

  • 主な調査結果
  • イントロダクション
  • プロゲスチンのみ
  • 複合ホルモン避妊薬

第7章 世界のホルモン避妊薬市場： 流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • その他

第8章 世界のホルモン避妊薬市場：地域別

  • 主な調査結果
  • イントロダクション
    • ホルモン避妊薬市場の評価：地域別、2019年～2032年
  • 北米
    • 北米：製品別、2019年～2032年
    • 北米：ホルモン別、2019年～2032年
    • 北米：流通チャネル別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2019年～2032年
    • 欧州：ホルモン別、2019年～2032年
    • 欧州：流通チャネル別、2019年～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品別、2019年～2032年
    • アジア太平洋：ホルモン別、2019年～2032年
    • アジア太平洋：流通チャネル別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2019年～2032年
    • 中東・アフリカ：ホルモン別、2019年～2032年
    • 中東・アフリカ：流通チャネル別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2019年～2032年
    • ラテンアメリカ：ホルモン別、2019年～2032年
    • ラテンアメリカ：流通チャネル別、2019年～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • HRA Pharma
  • Mithra Pharmaceuticals
  • Celgene Corporation
  • Allergan plc
  • Procter & Gamble Co.
  • Reddy's Laboratories Ltd.
図表

List of Tables:

  • Table 1 Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 3 Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 6 North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 8 U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 9 U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 12 Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 14 Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 15 Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 17 UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 18 UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 20 France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 21 France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 24 Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 27 Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 29 Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 30 Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 36 Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 38 Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 39 Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 42 Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 44 China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 45 China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 47 India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 48 India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 51 Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 54 Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 57 Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 59 South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 60 South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 62 Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 63 Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 65 Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 66 Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 69 Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 71 Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 72 Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 74 UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 75 UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 77 Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 78 Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 80 South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 81 South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 86 Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 87 Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 88 Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 89 Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 90 Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 92 Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 93 Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 95 Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 96 Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 97 Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 98 Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 99 Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures:

  • Figure 1. Global Hormonal Contraceptive Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Hormonal Contraceptive Market, by Product, 2023 & 2032 (USD Billion)
  • Figure 8. Market by Hormone
  • Figure 9. Global Hormonal Contraceptive Market, by Hormone, 2023 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Hormonal Contraceptive Market, by Distribution Channel, 2023 & 2032 (USD Billion)
目次
Product Code: PM2570

The global hormonal contraceptive market size is expected to reach USD 24.60 billion by 2032, according to a new study by Polaris Market Research. The report "Global Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product (Pills, Skin Patches, Intrauterine Devices, Hormonal Implants, Vaginal Rings, and Others), By Hormone, By Distribution Channel, and By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global hormonal contraceptive market is experiencing robust growth, driven by increasing awareness about family planning and reproductive health, rising adoption of hormonal contraceptives as a reliable method of birth control, and advancements in contraceptive technology. Key drivers include the growing emphasis on women's health and empowerment, supportive government initiatives and policies promoting contraceptive access, and the rising prevalence of sexually transmitted infections (STIs), which encourages preventive measures. Trends in the market show a shift towards innovative hormonal contraceptives, such as long-acting reversible contraceptives (LARCs), and a rising demand for personalized and convenient options like oral contraceptives and hormonal patches.

The hormonal contraceptive market in emerging markets is experiencing significant growth, driven by advancements in healthcare infrastructure and improving economic conditions. Also, investment in healthcare systems, access to a variety of contraceptive options is expanding, making hormonal contraceptives more widely available. Enhanced economic stability allows more individuals to afford and prioritize family planning services. Additionally, increased awareness and education about reproductive health contribute to higher demand. Governments and organizations are also focusing on improving access through public health initiatives and subsidies, further boosting availability. This growing market reflects a positive shift towards better reproductive health options and empowerment for women in emerging economies.

Hormonal Contraceptive Market Report Highlight

Oral contraceptive pills remain the dominant segment due to their widespread use, well-established efficacy, and long-standing consumer familiarity.

Progestin-Only Contraceptives, which include methods like progestin-only pills, implants, and injections, are increasingly popular due to their suitability for women who cannot use estrogen or prefer a single-hormone approach.

Retail pharmacies currently dominate the market due to their widespread accessibility and convenience for consumers.

The highest-growing segment is hospital pharmacies. This growth is fueled by increasing healthcare access and a rising focus on comprehensive reproductive health services within clinical settings.

North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, hormone, distribution channel and region

Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pills
  • Skin Patches
  • Intrauterine Devices
  • Hormonal Implants
  • Vaginal Rings
  • Others

Hormonal Contraceptive, Hormone Outlook (Revenue - USD Billion, 2019 - 2032)

  • Progestin Only
  • Combined Hormone Contraceptives

Hormonal Contraceptive, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hormonal Contraceptive Market Insights

  • 4.1. Hormonal Contraceptive Market - Market Snapshot
  • 4.2. Hormonal Contraceptive Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Long-Acting Reversible Contraceptives (LARCs) Is Driving the Market Growth
      • 4.2.1.2. Shift Towards Personalized and Convenient Contraceptive Options Propels the Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Health Concerns and Side Effects is hindering the Hormonal Contraceptive Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Hormonal Contraceptive Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hormonal Contraceptive Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Pills
    • 5.3.1. Global Hormonal Contraceptive Market, by Pills, by Region, 2019-2032 (USD Billion)
  • 5.4. Skin Patches
    • 5.4.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
  • 5.5. Hormonal Implants
    • 5.5.1. Global Hormonal Contraceptive Market, by Hormonal Implants, by Region, 2019-2032 (USD Billion)
  • 5.6. Vaginal Rings
    • 5.6.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2019-2032 (USD Billion)
  • 5.7. Skin Patches
    • 5.7.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Hormonal Contraceptive Market, by Hormone

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • 6.3. Progestin Only
    • 6.3.1. Global Hormonal Contraceptive Market, by Progestin Only, by Region, 2019-2032 (USD Billion)
  • 6.4. Combined Hormone Contraceptives
    • 6.4.1. Global Hormonal Contraceptive Market, by Combined Hormone Contraceptives, by Region, 2019-2032 (USD Billion)

7. Global Hormonal Contraceptive Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Hormonal Contraceptive Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Hormonal Contraceptive Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Hormonal Contraceptive Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Hormonal Contraceptive Market - North America
    • 8.3.1. North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.3.3. North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Hormonal Contraceptive Market - U.S.
      • 8.3.4.1. U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Hormonal Contraceptive Market - Canada
      • 8.3.5.1. Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Hormonal Contraceptive Market - Europe
    • 8.4.1. Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Hormonal Contraceptive Market - UK
      • 8.4.4.1. UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Hormonal Contraceptive Market - France
      • 8.4.5.1. France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Hormonal Contraceptive Market - Germany
      • 8.4.6.1. Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Hormonal Contraceptive Market - Italy
      • 8.4.7.1. Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Hormonal Contraceptive Market - Spain
      • 8.4.8.1. Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Hormonal Contraceptive Market - Netherlands
      • 8.4.9.1. Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Hormonal Contraceptive Market - Russia
      • 8.4.10.1. Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.11. Hormonal Contraceptive Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.11.2. Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.11.3. Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Hormonal Contraceptive Market - Asia Pacific
    • 8.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Hormonal Contraceptive Market - China
      • 8.5.4.1. China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Hormonal Contraceptive Market - India
      • 8.5.5.1. India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Hormonal Contraceptive Market - Malaysia
      • 8.5.6.1. Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Hormonal Contraceptive Market - Japan
      • 8.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Hormonal Contraceptive Market - Indonesia
      • 8.5.8.1. Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Hormonal Contraceptive Market - South Korea
      • 8.5.9.1. South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.10. Hormonal Contraceptive Market - Australia
      • 8.5.10.1. Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.10.2. Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.10.3. Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.11. Hormonal Contraceptive Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Hormonal Contraceptive Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Hormonal Contraceptive Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Hormonal Contraceptive Market - UAE
      • 8.6.5.1. UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Hormonal Contraceptive Market - Israel
      • 8.6.6.1. Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Hormonal Contraceptive Market - South Africa
      • 8.6.7.1. South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.8. Hormonal Contraceptive Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Hormonal Contraceptive Market - Latin America
    • 8.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Hormonal Contraceptive Market - Mexico
      • 8.7.4.1. Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Hormonal Contraceptive Market - Brazil
      • 8.7.5.1. Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Hormonal Contraceptive Market - Argentina
      • 8.7.6.1. Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.7. Hormonal Contraceptive Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bayer AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Pfizer Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merck & Co., Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Johnson & Johnson
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. AbbVie Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teva Pharmaceutical Industries Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novartis AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. HRA Pharma
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mithra Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Celgene Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Allergan plc
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Procter & Gamble Co.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Reddy's Laboratories Ltd.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development